Simpo, Florencia M.
HRN: 22-59-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/08/2023
CEFTAZIDIME 1GM (VIAL)
03/08/2023
03/21/2023
IV
1g
Q12
CVD Bleed, Intubated
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes